Skip to main content
Recall Canary
Amnesteem Isotretinoin Capsules 40 mg
← Back to all recalls
DRUG RECALLMODERATE

Amnesteem Isotretinoin Capsules 40 mg

Mylan is recalling Amnesteem Isotretinoin 40 mg capsules (NDC 0378-6614-93) due to failed dissolution specifications.

What to do

Do not use this medication without consulting your healthcare provider or pharmacist. Contact your pharmacy or doctor immediately if you have this product to determine whether you should continue taking it or switch to an alternative medication. Return the product to your pharmacy.

Posted
Updated
Recall No.
D-0399-2026
Agency
Firm
MYLAN PHARMACEUTICALS INC
Recall ID
98477
Status
ONGOING

Why it was recalled

Mylan Pharmaceuticals is recalling Amnesteem (Isotretinoin) Capsules, USP 40 mg, packaged in 3 x 10-Count Prescription Packs (NDC 0378-6614-93) due to failed dissolution specifications. The affected product was manufactured in France and distributed nationwide. Patients should contact their healthcare provider or pharmacist before discontinuing use.

Is mine affected?

Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.

Amnesteem (Isotretinoin) Capsules, USP 40 mg, packaged in 3 x 10-Count Prescription Packs, Rx Only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV, 26505 USA, Made in France, NDC 0378-6614-93.

Recall #
D-0399-2026

Where it was sold

Distributed nationwide.

Other recent recalls from MYLAN PHARMACEUTICALS INC

← Back to all recalls

Editorial summary by Recall Canary · last updated 2026-04-27 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification